Clinical Trial Update: A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia [Phase 3]

View source ↗

Summary

Phase 3 trial of NeoRecormon (epoetin beta) in patients with chronic renal anemia has completed and results were posted. The sponsor is Hoffmann-La Roche.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-05-25